Trial intelligence / Profile preview

Cypropofol plus low-dose sufentanil vs propofol plus low-dose sufentanil for sedation in painless cystoscopy

ChiCTR2500096071Phase 4Not yet recruiting

Sponsor
Nanchong City Central Hospital
Start
Jan 2025
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ciprofol in None (2 arms), sponsored by Nanchong City Central Hospital. Primary endpoints: Induction time of anesthesia, Checking operation time and 3 more. Planned start Jan 2025; status: not yet recruiting.

02

Drugs

ciprofol

Beyond the preview

Go deeper on ChiCTR2500096071.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500096071.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call